Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular gluteal versus intra-articular corticosteroid injection for knee osteoarthritis
NL-OMON48857Phase 4Active, not recruiting
- Sponsor
- Huisartsgeneeskunde
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of triamcinolone acetonide in knee osteoarthritis (OA) (2 arms), sponsored by Huisartsgeneeskunde. Primary endpoint: KOOS pain at 4 weeks. Started Jun 2018; status: active, not recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NL-OMON48857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48857.